CoChat

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

Open access

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Rationale: The optimal timing for listing of cystic fibrosis patients for lung transplantation is controversial. Objectives: We conducted a retrospective cohort study of 343 patients listed for lung transplantation at four academic medical centers to identify risk factors for death while awaiting transplantation. Methods: Data on possible risk factors were abstracted from medical records. Measurements: Time to death, patient demographic characteristics, and risk factors for death while awaiting transplantation were assessed. Univariate and multivariate survival analyses were performed using Cox regression. Results: By univariate analyses, FEV1 ⩽ 30% predicted (HR, 3.8; 95% CI, 2.0–7.5), PaCO2 ⩾ 50 mm Hg (HR, 1.85; 95% CI, 1.1–3.0), and shorter height (HR, 1.8; 95% CI, 1.1–3.0) were associated with a higher risk of death. Referral from an accredited cystic fibrosis center was associated with a lower risk (HR, 0.53; 95% CI, 0.30–0.92). The final multivariate model included referral from an accredited cystic fibrosis center (HR, 0.5; 95% CI, 0.3–1.0) and listing year after 1996 (HR, 0.4; 95% CI, 0.2–0.7); both were associated with a lower risk of death. FEV1 ⩽ 30% predicted (HR, 6.8; 95% CI, 2.4–19.3), PaCO2 ⩾ 50 mm Hg (HR, 6.9; 95% CI, 1.5–32.1), and use of a nutritional intervention (HR, 2.3; 95% CI, 1.3–4.1) were associated with increased risk. Patients with FEV1 > 30% predicted had a higher risk of death only when their PaCO2 was ⩾ 50 mm Hg (HR, 7.0; 95% CI, 1.5–32), while the increased risk of death with FEV1 ⩽ 30% was not further influenced by the presence of hypercapnia. Conclusions: We identified risk factors for waiting list mortality that could impact on transplant listing and allocation guidelines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.200410-1369oc

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 6

  1. 2001, Pediatr Pulmonol, 32, 317
  2. 2004, Pediatr Pulmonol, 38, 317
  3. 1998, J Heart Lung Transplant, 17, 703
  4. 1997, J Heart Lung Transplant, 16, 313
  5. 2001, J Heart Lung Transplant, 20, 242
  6. 2001, Eur J Med Res, 6, 345

Cited by

See all 180

Metadata

Authors
Belkin, R. A., Henig, N. R., Singer, L. G., Chaparro, C., Rubenstein, R. C., Xie, S. X., Yee, J. Y., Kotloff, R. M., Lipson, D. A., & Bunin, G. R.
Affiliations
University Health Network (CA)
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2006-03
Volume
173
Issue
6
Pages
659-666
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2045873707
Cited by
180
References
40
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 9 · 2022: 3 · 2021: 11 · 2020: 10 · 2019: 12 · 2018: 15 · 2017: 10 · 2016: 10 · 2015: 12 · 2014: 9 · 2013: 13 · 2012: 12
FWCI
6.05
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cystic Fibrosis Foundation
  • National Institutes of Health (1f32hl074534-01)
  • National Heart, Lung, and Blood Institute (F32 HL74534-01)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
Keywords
cystic fibrosis, lung transplantation, transplant listing, mortality risk factors, hypercapnia, FEV1, hypercapnic respiratory failure, dietary intervention, waiting lists
MeSH terms
Adult, Cause of Death, Child, Cystic Fibrosis, Female, Follow-Up Studies, Forced Expiratory Volume, Humans, Male, Prognosis, Retrospective Studies, Risk Factors, Severity of Illness Index, Waiting Lists, Survival Rate, Proportional Hazards Models, Lung Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation. https://app.cochat.ai/papers/10.1164/rccm.200410-1369oc
The paper
Belkin, R. A., Henig, N. R., Singer, L. G., Chaparro, C., Rubenstein, R. C., Xie, S. X., Yee, J. Y., Kotloff, R. M., Lipson, D. A., & Bunin, G. R. (2006). Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200410-1369oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.